The pharmaceuticals market in India is witnessing significant growth, with anti-diabetic drugs leading the way with over ₹155 crore in valu...

India's pharma market took a dip in March after poor sales of respiratory and anti-infective therapies dropped post-winter. April saw the m...

"We have seen a sharp rise in the sales of drugs like paracetamol, analgesics and drugs for respiratory illnesses," said Rajiv Singhal, gen...

Cipla claimed that the price of the powdered form of its three asthma drugs were capped without following the proper procedure prescribed u...